Skip to main content
eScholarship
Open Access Publications from the University of California

UCSF

UC San Francisco Previously Published Works bannerUCSF

A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease.

  • Author(s): Doyle, Tracy J;
  • Lee, Joyce S;
  • Dellaripa, Paul F;
  • Lederer, James A;
  • Matteson, Eric L;
  • Fischer, Aryeh;
  • Ascherman, Dana P;
  • Glassberg, Marilyn K;
  • Ryu, Jay H;
  • Danoff, Sonye K;
  • Brown, Kevin K;
  • Collard, Harold R;
  • Rosas, Ivan O
  • et al.

Published Web Location

https://doi.org/10.1378/chest.13-2408
No data is associated with this publication.
Abstract

Rheumatoid arthritis (RA) is a systemic inflammatory disorder affecting approximately 1.3 million adults in the United States. Approximately 10% of these individuals with RA have clinically evident interstitial lung disease (RA-ILD), and an additional one-third demonstrate subclinical ILD on chest CT scan. The risk of death for individuals with RA-ILD is three times higher than for patients with RA without ILD, with a median survival after ILD diagnosis of only 2.6 years. Despite the high prevalence and mortality of RA-ILD, little is known about its molecular features and its natural history. At present, we lack a standard validated approach to the definition, diagnosis, risk stratification, and management of RA-ILD. In this perspective, we discuss the importance of clinical and translational research and how ongoing research efforts can address important gaps in our knowledge over the next few years. Furthermore, recommendations are made to design multicenter collaborative studies that will expedite the development of clinical trials designed to decrease the significant morbidity and mortality associated with RA-ILD.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.



The text for this item is currently unavailable.